Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing v3.5.3. This represents a routine page revision without changes to the study data or on-page sections describing the trial.SummaryDifference0.0%

- Check20 days agoChange DetectedAdds a new LEAP-005 publication entry detailing results for gastric, biliary tract, and pancreatic cancers to the Publications section. Removes several 2025 postings from Publications, updating the record with newer citations.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s interface revision/version label was updated to a newer revision (v3.5.3) without changing the underlying study details shown on the record.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded Temuco, Araucania, Chile, 4780000 as a new site and removed Temuco, Región de la Araucanía, Chile, 4780000, updating the region name from Región de la Araucanía to Araucania. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedNaples, Italy (80131) was added as a study site and Napoli, Italy (80131) was removed; Abbotsford listing formatting was updated to Abbotsford British Columbia, British Columbia, Canada, V2S 0C2.SummaryDifference0.1%

- Check70 days agoChange Detected- Revision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.